Riskpilot← Back to searchSign inGet full accessAlamoriz Medico AB
ABActiveOrg 5590302781Rotnäsvägen 64 AHospital activities · NACE 8610Est. 20151-4 employees
Revenue 2024
SEK 1,5M
-47% vs 2023
EBITDA margin
-1.7%
-101% vs 2023
Equity ratio
41.7%
Financial strength
Net profit 2024
SEK 64K
-93% vs 2023
| Revenue | SEK 1,5M | -47% |
| EBITDA | SEK -25K | -101% |
| Net profit | SEK 64K | -93% |
| Total assets | SEK 10,2M | -7% |
| Equity | SEK 4,2M | -7% |
| Employees | — | — |
Legal name
Alamoriz Medico AB
Org number
5590302781
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
14 oktober 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva vårdföretag med läkartjänster, äga och förvalta fastigheter, aktier, värdepapper och därmed förenlig verksamhet.
Address
Rotnäsvägen 64 A
Email
mou_am@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 841 | 3 099 | 3 066 | 2 790 | 1 465 |
| Staff expenses | — | — | −1 001 | −1 107 | −1 003 |
| EBITDA | 1 719 | 1 686 | 1 962 | 1 834 | −25 |
| Depreciation & amort. | −219 | −232 | −115 | −163 | −248 |
| EBIT | 1 500 | 1 454 | 1 847 | 1 671 | −273 |
| Net financials | −73 | −89 | −128 | −263 | −130 |
| Profit before tax | 1 163 | 1 054 | 1 419 | 1 269 | 147 |
| Tax | −254 | −222 | −300 | −297 | −82 |
| Net profit | 909 | 832 | 1 119 | 971 | 64 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 532 | 10 083 | 10 997 | 10 917 | 10 178 |
| Equity | 2 576 | 3 158 | 3 917 | 4 557 | 4 248 |
| Long-term debt | 4 725 | 4 639 | 4 560 | 3 682 | 3 576 |
| Short-term debt | 761 | 505 | 439 | 459 | 684 |
| Total debt | 5 486 | 5 144 | 4 999 | 4 140 | 4 260 |
EBITDA margin
-1.7%
This company
15.8%
Market median
-111% vs market
20202024
Equity ratio
41.7%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
1.5%
This company
18.4%
Market median
-92% vs market
20202024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20202024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AT | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alamoriz Medico AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Tommy Holgersson | Audit | 0 companies |
| Amer Mousa Kadhem | Board of Directors | 0 companies |
| Rafal Abdelsattar Mahdi | Deputy Board Member | 0 companies |